Vaccine Development Opportunity: Universal Influenza Vaccine Candidate

Vaccine Development Opportunity:

Universal Influenza Vaccine Candidate

Colorized transmission electron micrograph showing H1N1 influenza virus particles. Surface proteins on the virus particles are shown in black. Credit: NIAID

NIAID scientists in the Laboratory of Infectious Diseases are developing a promising universal influenza vaccine candidate, with the goal of creating a vaccine that is broadly protective against various influenza virus strains and subtypes. This virus-like particle (VLP) vaccine technology is based on a mixture of VLPs expressing the hemagglutinin protein or the neuraminidase protein from influenza virus strains belonging to different virus subtypes. Read more about this exciting collaboration/licensing opportunity: https://www.ott.nih.gov/technology/e-089-2002